Dyadic International DYAI
NASDAQ DYAI
$0.43 -0.01 (-3.37%)
At close: Oct 1, 2026 · 4:00 PM EDT

Dyadic International (DYAI) Share-based Compensation (2018 - 2026)

Updated

Dyadic International's Share-based Compensation was $139,299 in Q1 2026, down 38.1% from $225,030 a year earlier and down 27.6% from the prior quarter.

Analysis

Dyadic International (DYAI) Share-based Compensation (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Dyadic International's Share-based Compensation was $844,452 through Mar 31, 2026, down 19.2% year-over-year; for FY2025, it came in at $930,183, down 17.4% from FY2024.

  • Share-based Compensation has now declined for three consecutive years, with a five-year compound annual growth rate of -10.9% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $1.13 million in FY2024 (-9.5%), $1.24 million in FY2023 (-34.1%), $1.89 million in FY2022 (+5.9%) and $1.78 million in FY2021 (+8.0%).
  • The Q1 2026 figure marks the lowest quarterly Share-based Compensation since Q2 2021.
  • Compared with a year earlier, Share-based Compensation has declined for three straight quarters, with an average decline of 17.7% over the last eight quarters.
  • The best year-over-year quarter for Share-based Compensation over five years was Q4 2021 (growth of 18.6%); the worst was Q1 2022 (a decline of 99.9%).
  • Per Business Quant data, DYAI's Share-based Compensation in the three quarters before Q1 2026 was $192,339 (Q4 2025), $172,352 (Q3 2025) and $340,462 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 458.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 166.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 231.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 170.20 Mn
10 Dyadic International 16.03 Mn 9.43 Mn - 139,299.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 139,299.00
Dec 31, 2025 192,339.00
Sep 30, 2025 172,352.00
Jun 30, 2025 340,462.00
Mar 31, 2025 225,030.00
Dec 31, 2024 274,808.00
Sep 30, 2024 247,390.00
Jun 30, 2024 297,603.00
Mar 31, 2024 306,478.00
Dec 31, 2023 297,859.00
Sep 30, 2023 281,307.00
Jun 30, 2023 334,316.00
Mar 31, 2023 330,639.00
Dec 31, 2022 480,734.00
Sep 30, 2022 499,919.00
Jun 30, 2022 454,500.00
Mar 31, 2022 453,791.00
Dec 31, 2021 459,702.00
Sep 30, 2021 457,209.00
Jun 30, 2021 -420.20 Mn
API Access

Dyadic International Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=DYAI&period=max&api_key=YOUR_API_KEY